1. Rouffy J, Sauvanet JP, Chann B, Bakir R, Goy-Leper J, Saya C, Pinaroli F (1980) Evaluation à long terme de l'activitè hypolipidèmiante et de la tolerance du fénofibrate. Nouv. Presse Med 9: 3747?3751
2. Sommariva D, Bonfiglioli D, Pogliaghi I, Zanaboni L, Balboni E, Paolino C, Fasoli A (1983) Effects of procetofen on serum lipids and lipoproteins and on plasma post-heparin lipase activities in type II and in type IV hyperlipoproteinemic patients. Curr Ther Res 34: 907?915
3. Wulfert E (1978) Activity of 3-hydroxy-3-methylglutaryl Coenzyme A reducatse from rat and guinea pig liver. Specific inhibition studies and affinity chromatography. In: Kritchewsky D, Paoletti R, Holmes WL (eds) Drugs, lipid metabolism and atherosclerosis. Plenum Press, New York, p 19
4. Wulfert E (1980) Le fénofibrate: par quel mécanisme produitil son effet hypocholestérolémiante? Nouv Presse Med 9: 3733?3736
5. Massaroli C, Sommariva D, Bortolini U, Paolino C, Fasoli A (1982) Inactivation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase in cultured human blood mononuclear cells by procetofenic acid. Pharmacol Res Commun 14: 51?60